524 related articles for article (PubMed ID: 18054317)
1. Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosis.
Miyazaki M; Flowers MT; Sampath H; Chu K; Otzelberger C; Liu X; Ntambi JM
Cell Metab; 2007 Dec; 6(6):484-96. PubMed ID: 18054317
[TBL] [Abstract][Full Text] [Related]
2. Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1α-FGF21 axis in mice.
Aljohani A; Khan MI; Bonneville A; Guo C; Jeffery J; O'Neill L; Syed DN; Lewis SA; Burhans M; Mukhtar H; Ntambi JM
J Biol Chem; 2019 Dec; 294(51):19475-19485. PubMed ID: 31690632
[TBL] [Abstract][Full Text] [Related]
3. ATF4 deficiency protects mice from high-carbohydrate-diet-induced liver steatosis.
Li H; Meng Q; Xiao F; Chen S; Du Y; Yu J; Wang C; Guo F
Biochem J; 2011 Sep; 438(2):283-9. PubMed ID: 21644928
[TBL] [Abstract][Full Text] [Related]
4. Stearoyl-CoA desaturase as a new drug target for obesity treatment.
Dobrzyn A; Ntambi JM
Obes Rev; 2005 May; 6(2):169-74. PubMed ID: 15836467
[TBL] [Abstract][Full Text] [Related]
5. Hepatic oleate regulates liver stress response partially through PGC-1α during high-carbohydrate feeding.
Liu X; Burhans MS; Flowers MT; Ntambi JM
J Hepatol; 2016 Jul; 65(1):103-112. PubMed ID: 26976120
[TBL] [Abstract][Full Text] [Related]
6. Diet-induced changes in stearoyl-CoA desaturase 1 expression in obesity-prone and -resistant mice.
Hu CC; Qing K; Chen Y
Obes Res; 2004 Aug; 12(8):1264-70. PubMed ID: 15340109
[TBL] [Abstract][Full Text] [Related]
7. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
Liu LF; Purushotham A; Wendel AA; Belury MA
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
[TBL] [Abstract][Full Text] [Related]
8. Cideb regulates diet-induced obesity, liver steatosis, and insulin sensitivity by controlling lipogenesis and fatty acid oxidation.
Li JZ; Ye J; Xue B; Qi J; Zhang J; Zhou Z; Li Q; Wen Z; Li P
Diabetes; 2007 Oct; 56(10):2523-32. PubMed ID: 17646209
[TBL] [Abstract][Full Text] [Related]
9. Leptin suppresses stearoyl-CoA desaturase 1 by mechanisms independent of insulin and sterol regulatory element-binding protein-1c.
Biddinger SB; Miyazaki M; Boucher J; Ntambi JM; Kahn CR
Diabetes; 2006 Jul; 55(7):2032-41. PubMed ID: 16804073
[TBL] [Abstract][Full Text] [Related]
10. Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistance.
Gutiérrez-Juárez R; Pocai A; Mulas C; Ono H; Bhanot S; Monia BP; Rossetti L
J Clin Invest; 2006 Jun; 116(6):1686-95. PubMed ID: 16741579
[TBL] [Abstract][Full Text] [Related]
11. Oleate activates SREBP-1 signaling activity in
Lounis MA; Bergeron KF; Burhans MS; Ntambi JM; Mounier C
Am J Physiol Endocrinol Metab; 2017 Dec; 313(6):E710-E720. PubMed ID: 28851735
[TBL] [Abstract][Full Text] [Related]
12. Lipid Emulsion Added to a Liquid High-Carbohydrate Diet and Voluntary Running Exercise Reduce Lipogenesis and Ameliorate Early-Stage Hepatic Steatosis in Mice.
Huang KH; Hao L; Smith PB; Rogers CJ; Patterson AD; Ross AC
J Nutr; 2017 May; 147(5):746-753. PubMed ID: 28298542
[No Abstract] [Full Text] [Related]
13. Hepatic Oleate Regulates Insulin-like Growth Factor-Binding Protein 1 Partially through the mTORC1-FGF21 Axis during High-Carbohydrate Feeding.
O'Neill LM; Phang YX; Liu Z; Lewis SA; Aljohani A; McGahee A; Wade G; Kalyesubula M; Simcox J; Ntambi JM
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498997
[TBL] [Abstract][Full Text] [Related]
14. Daidzein supplementation prevents non-alcoholic fatty liver disease through alternation of hepatic gene expression profiles and adipocyte metabolism.
Kim MH; Park JS; Jung JW; Byun KW; Kang KS; Lee YS
Int J Obes (Lond); 2011 Aug; 35(8):1019-30. PubMed ID: 21157426
[TBL] [Abstract][Full Text] [Related]
15. SCD1 deficiency protects mice against ethanol-induced liver injury.
Lounis MA; Escoula Q; Veillette C; Bergeron KF; Ntambi JM; Mounier C
Biochim Biophys Acta; 2016 Nov; 1861(11):1662-1670. PubMed ID: 27477676
[TBL] [Abstract][Full Text] [Related]
16. The role of stearoyl-CoA desaturase in the control of metabolism.
Dobrzyn A; Ntambi JM
Prostaglandins Leukot Essent Fatty Acids; 2005 Jul; 73(1):35-41. PubMed ID: 15941655
[TBL] [Abstract][Full Text] [Related]
17. High hepatic SCD1 activity is associated with low liver fat content in healthy subjects under a lipogenic diet.
Silbernagel G; Kovarova M; Cegan A; Machann J; Schick F; Lehmann R; Häring HU; Stefan N; Schleicher E; Fritsche A; Peter A
J Clin Endocrinol Metab; 2012 Dec; 97(12):E2288-92. PubMed ID: 23015656
[TBL] [Abstract][Full Text] [Related]
18. Reduced adiposity and liver steatosis by stearoyl-CoA desaturase deficiency are independent of peroxisome proliferator-activated receptor-alpha.
Miyazaki M; Dobrzyn A; Sampath H; Lee SH; Man WC; Chu K; Peters JM; Gonzalez FJ; Ntambi JM
J Biol Chem; 2004 Aug; 279(33):35017-24. PubMed ID: 15180999
[TBL] [Abstract][Full Text] [Related]
19. Stearoyl-CoA desaturase deficiency, hypercholesterolaemia, cholestasis and diabetes.
Attie AD; Flowers MT; Flowers JB; Groen AK; Kuipers F; Ntambi JM
Novartis Found Symp; 2007; 286():47-53; discussion 54-7, 162-3, 196-203. PubMed ID: 18269173
[TBL] [Abstract][Full Text] [Related]
20. Role for PPARγ in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts.
Morán-Salvador E; López-Parra M; García-Alonso V; Titos E; Martínez-Clemente M; González-Périz A; López-Vicario C; Barak Y; Arroyo V; Clària J
FASEB J; 2011 Aug; 25(8):2538-50. PubMed ID: 21507897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]